Product NDC: | 45802-400 |
Proprietary Name: | Ciclopirox Olamine |
Non Proprietary Name: | Ciclopirox Olamine |
Active Ingredient(s): | 7.7 mg/100mL & nbsp; Ciclopirox Olamine |
Administration Route(s): | TOPICAL |
Dosage Form(s): | SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 45802-400 |
Labeler Name: | Perrigo New York Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077676 |
Marketing Category: | ANDA |
Start Marketing Date: | 20061229 |
Package NDC: | 45802-400-49 |
Package Description: | 1 BOTTLE in 1 CARTON (45802-400-49) > 30 mL in 1 BOTTLE |
NDC Code | 45802-400-49 |
Proprietary Name | Ciclopirox Olamine |
Package Description | 1 BOTTLE in 1 CARTON (45802-400-49) > 30 mL in 1 BOTTLE |
Product NDC | 45802-400 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Ciclopirox Olamine |
Dosage Form Name | SUSPENSION |
Route Name | TOPICAL |
Start Marketing Date | 20061229 |
Marketing Category Name | ANDA |
Labeler Name | Perrigo New York Inc |
Substance Name | CICLOPIROX OLAMINE |
Strength Number | 7.7 |
Strength Unit | mg/100mL |
Pharmaceutical Classes | Decreased DNA Replication [PE],Decreased Protein Synthesis [PE],Decreased RNA Replication [PE],Protein Synthesis Inhibitors [MoA] |